ARHGAP35

Rho GTPase Activating Protein 35

Gene Information Card

Symbol ARHGAP35
Full Name Rho GTPase Activating Protein 35
Gene Type Protein coding
Chromosomal Location 19q13.32
NCBI Gene ID 2909 ncbi.nlm.nih.gov/gene/2909
Ensembl ID ENSG00000160007
UniProt ID Q9NRY4
OMIM ID 605277
HGNC ID 676
Aliases p190RhoGAP, GRF-1, GRLF1, p190-A, p190A

Description

ARHGAP35 encodes a member of the Rho GTPase-activating protein (RhoGAP) family. The protein, p190RhoGAP, stimulates the intrinsic GTPase activity of Rho family GTPases (RhoA, Rac1, Cdc42), converting them to the inactive GDP-bound state. It functions as a tumor suppressor by negatively regulating Rho-mediated signaling, cell migration, and proliferation. ARHGAP35 is frequently mutated or deleted in various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer Loss of function mutations lead to increased RhoA activity, promoting invasion and metastasis. COSMIC, ClinVar
Lung adenocarcinoma Somatic mutations and deletions reduce GAP activity, enhancing tumor growth. COSMIC, NCBI Gene
Colorectal cancer Frameshift and nonsense mutations contribute to Rho pathway hyperactivation. COSMIC, ClinVar
Endometrial cancer Recurrent mutations in the RhoGAP domain impair GTP hydrolysis. COSMIC
Glioblastoma Decreased expression correlates with poor prognosis and increased cell motility. NCBI Gene

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Lung 8.3 Low
Breast 7.1 Low
Colon 6.9 Low
Ovary 9.8 Low
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 10.2 Moderate expression
A549 (lung cancer) 7.5 Low expression
HCT116 (colorectal cancer) 6.8 Low expression
HEK293 (embryonic kidney) 11.0 Moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.2101C>T (p.Gln701*) Nonsense <1% in breast cancer Truncation, loss of GAP domain
c.1234_1235del (p.Lys412fs) Frameshift <1% in colorectal cancer Loss of function
c.2560G>A (p.Gly854Arg) Missense <1% in lung adenocarcinoma Impaired GTPase activation
c.1789C>T (p.Arg597*) Nonsense <1% in endometrial cancer Premature stop, loss of function
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations that truncate the protein, particularly within the RhoGAP domain, result in loss of GTPase-activating activity and tumor suppressor function.

Gain of Function (GOF)

No gain-of-function mutations have been reported for ARHGAP35.

Dominant Negative (DN)

No dominant-negative mutations have been characterized for ARHGAP35.

Gene Ontology (GO)

• GTPase activator activity • Rho GTPase binding
• regulation of cell migration • negative regulation of cell proliferation
• actin cytoskeleton organization

Pathways

Rho GTPase cycle
Signaling by Rho family GTPases
Regulation of actin dynamics for phagocytic cup formation

Protein Summary

ARHGAP35 encodes p190RhoGAP, a 190 kDa protein containing an N-terminal GTPase-binding domain and a C-terminal RhoGAP domain. It inactivates RhoA, Rac1, and Cdc42 by accelerating GTP hydrolysis. The protein localizes to the cytoplasm and focal adhesions, regulating cytoskeletal dynamics, cell adhesion, and migration. Loss of function contributes to oncogenic transformation.

Related Products

Product name Cat.No. Species Gene ID
ARHGAP35 Knockout HEK293 Cell Line EDJ-KQ4796 Human 2909 Details Get a Quote
ARHGAP35 Knockout A-549 Cell Line EDJ-KQ27561 Human 2909 Details Get a Quote
ARHGAP35 Knockout HCT 116 Cell Line EDJ-KQ27562 Human 2909 Details Get a Quote
ARHGAP35 Knockout HeLa Cell Line EDJ-KQ27563 Human 2909 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: